KFDA publishes BT report

Published: 2004-06-11 06:56:00

Updated: 2004-06-11 06:56:00

The Korea Food and Drug Administration says it has recently published a report to facilitate efforts of those engaged in the domestic biotechnology sector, which is divided into two sections platform technology for evaluating the safety of BT items and safety management of cell drugs.

The fir...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK